# CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

> **NCT02274584** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking University** · enrollment: 20 (estimated)

## Conditions studied

- Lymphomas

## Interventions

- **GENETIC:** Anti-CD30 CAR T cells

## Key facts

- **NCT ID:** NCT02274584
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02274584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02274584, "CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02274584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*